French Personal Products Stock News

Active investing isn't easy, but for those that do it, the aim is to find the best companies to buy, and to profit...

If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

When you see that almost half of the companies in the Software industry in France have price-to-sales ratios (or "P/S...

With its stock down 38% over the past three months, it is easy to disregard Aramis Group SAS (EPA:ARAMI). However...

Poulaillon SA's ( EPA:ALPOU ) investors are due to receive a payment of €0.08 per share on 7th of April. The dividend...

One thing we could say about the analysts on Ayvens ( EPA:AYV ) - they aren't optimistic, having just made a major...

Dassault Systèmes SE ( EPA:DSY ) shareholders that were waiting for something to happen have been dealt a blow with a...

Equasens Société anonyme ( EPA:EQS ), is not the largest company out there, but it received a lot of attention from a...

Etablissements Maurel & Prom (ENXTPA:MAU) has drawn attention after reporting fourth quarter and full year 2025 figures that combined higher oil production with lower annual sales revenue compared with the previous year. See our latest analysis for Etablissements Maurel & Prom. The mixed 2025 update seems to be landing in a positive way with investors, with the share price at €7.39 after a 30 day share price return of 25.68% and a 90 day gain of 50.14%. The 5 year total shareholder return of...

Sanofi's ENXTPA:SAN rilzabrutinib received breakthrough therapy designation from the US FDA for warm autoimmune hemolytic anemia. The same drug received orphan drug designation from Japanese health authorities for this rare blood disorder. Sanofi reported progress in its rare disease pipeline, including late stage data for venglustat in neurological Gaucher disease and regulatory steps for Rezurock in Europe. The company is also expanding its use of AI in drug discovery and manufacturing to...

Engie (ENXTPA:ENGI) is taking a central role in South Africa's electricity transmission grid expansion, supporting power sector reform and policy discussions. The company is working to link grid decarbonisation with technology deployment and regulatory engagement in a major emerging market. Engie has also appointed Ernesto Parra as Managing Director for Saudi Arabia, strengthening leadership in another core region. Engie, trading at €26.69, sits at the intersection of large scale...

If you are asking yourself whether BNP Paribas is fairly priced or still offering value at current levels, you are in the right place. The stock last closed at €92.70, with returns of 1.9% over 7 days, 6.6% over 30 days, 13.2% year to date, 43.8% over 1 year, 81.4% over 3 years and 175.2% over 5 years. Recent attention around BNP Paribas has focused on its position as a major European bank and on how investors view large financial institutions in the current rate and regulatory cycle. These...

Gecina (ENXTPA:GFC) has put fresh numbers on the table for FY 2025, reporting first half revenue of €463.6 million and basic EPS of €3.91, while trailing twelve month revenue stands at €865.4 million and EPS at €6.88. Over the last three reported half year periods, revenue has moved from €442.6 million in 2024 H1 to €401.8 million in 2024 H2 and then to €463.6 million in 2025 H1. Over the same intervals, basic EPS shifted from €1.21 to €2.98 and then to €3.91. With a net margin of 52.2% over...

Redbreast, part of Pernod Ricard’s Irish whiskey portfolio, has introduced the Redbreast Moscatel Wine Cask Edition. This limited-edition release is finished in Moscatel wine casks sourced from Spain. The launch highlights Pernod Ricard (ENXTPA:RI) and its focus on premium and specialty cask whiskeys. Pernod Ricard, through Redbreast, is leaning further into premium Irish whiskey with a release built around Moscatel wine casks from Spain. For investors watching ENXTPA:RI, this kind of small...

Elis (ENXTPA:ELIS) is back in focus after reporting fourth quarter 2025 revenue of €1,205.7 million and full year revenue of €4,796.8 million, both above the levels reported a year earlier. See our latest analysis for Elis. The revenue update has come as Elis shares trade at €26.86, with a 1-day share price return of 1.13% and a 30-day share price return of 8.57%. The 1-year total shareholder return of 44.21% and 5-year total shareholder return of 122.30% point to momentum that has been...

Recent share performance context With no single headline event driving trading, Air France-KLM (ENXTPA:AF) has still seen its share price move around, including a 2.4% decline over the past day and gains over the past week and month. For investors tracking the stock, that short term volatility sits alongside a 26.2% total return over the past 3 months and 48.2% over the past year, set against a slightly negative year to date performance. See our latest analysis for Air France-KLM. At a share...

In late January 2026, Manitou BF reported its fourth-quarter and full-year 2025 sales, with quarterly net sales rising to €721 million from €656 million a year earlier, while nine-month sales were €2,564 million versus €2,656 million. At the same time, the company issued full-year 2026 guidance calling for revenue to increase by around 4% over 2025, giving investors a clearer view of its expected top-line trajectory. We will now examine how Manitou BF’s new 2026 revenue growth guidance...

If you are wondering whether Capgemini is starting to look attractively priced or still has room to fall, you are asking the right question for where the stock sits today. Capgemini shares last closed at €113.60, with returns of a 6.8% decline over 7 days, a 24.7% decline over 30 days, a 19.3% decline year to date, a 35.2% decline over 1 year, a 34.8% decline over 3 years and a 9.7% decline over 5 years. Recent share price moves are occurring against a backdrop of ongoing sector wide...

L'Oréal (ENXTPA:OR) has drawn fresh attention after backing P2 Science through its L’AcceleratOR fund and joining Ottawa’s Reuse City project, both focused on sustainable ingredients and reusable packaging. See our latest analysis for L'Oréal. With the share price at €391.4 and a 90 day share price return of 9.67%, L'Oréal’s recent sustainability moves come against a backdrop of building momentum, supported by a 1 year total shareholder return of 16.74% and a 5 year total shareholder return...

EgyptAir has taken delivery of its first Airbus A350-900, becoming the launch operator of the type in North Africa as it starts a long haul fleet renewal. Airbus has renewed its multi year technology partnership with Palantir Technologies to continue developing and running the Skywise aviation data platform. Delta Air Lines has agreed new aircraft orders with Airbus, while Philippine Airlines has signed fresh support and services contracts. Airbus, traded as ENXTPA:AIR, sits at a current...

If you are looking at Getlink and wondering whether €17.20 per share is a fair price or an opportunity, you are in the right place for a closer look at what that means for value. Over shorter periods the stock has posted returns of 2.2% over 7 days, 4.6% over 30 days, 8.1% year to date, 12.5% over 1 year, 14.5% over 3 years and 43.3% over 5 years. This naturally raises questions about how much of the story is already reflected in the current price. Recent news flow around Getlink has focused...

If you are looking at LVMH Moët Hennessy - Louis Vuitton Société Européenne and wondering whether the current share price reflects its true worth, this article is going to focus squarely on what you are paying versus what you are getting. The stock last closed at €537.70, with a 1.6% gain over the past 7 days, but returns of 17.5% decline over 30 days, 16.2% decline year to date, 19.6% decline over 1 year and 29.7% decline over 3 years contrast with an 8.7% gain over 5 years. Recent coverage...